Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOKYO.L Regulatory News (OKYO)

  • There is currently no data for OKYO

Directors' dealing

27 Jul 2015 07:00

RNS Number : 0918U
West African Minerals Corporation
27 July 2015
 

27 July 2015

For immediate release

West African Minerals Corporation

("WAFM" or the "Company")

Director's dealing

 

The Company announces that it was informed on 24 July 2015 that CE Mining Limited ("CE Mining") assigned on 24 July 2015 its entire holding of warrants to subscribe for new ordinary shares in the Company to CE Mining Fund II WAFM Limited ("Fund SPV"), a special purpose company established by CE Mining GP II Limited ("Fund GP") in its capacity as general partner of CE Mining Fund II L.P. Brad Mills, a director of the Company, is the controlling shareholder of Plinian Guernsey Limited ("Plinian"), which owns 50 per cent. of CE Mining and also the controlling shareholder of CE Mining Holding II Limited, which owns 100 per cent. of Fund GP.

CE Mining has assigned 5,071,429 warrants to Fund SPV ("CE Mining Warrants") for US$49,438. Each CE Mining Warrant, which was issued to CE Mining on 14 February 2014 is exercisable into one new ordinary share in the Company at an exercise price of 10p per ordinary share on or before the second anniversary of the date of admission of the 52,797,738 ordinary shares in the Company issued pursuant to the placing approved by the Company on 4 February 2014.

Following the assignment of the CE Mining Warrants, CE Mining has no remaining holding of warrants.

Brad Mills' interest in the share capital of the Company following the assignment remains as follows:

Shareholding

% interest in the issued share capital

Number of Options

Term (from May 2014)

 

Exercise Price (pence)

43,655,233

11.45%

4,700,000

10 yrs

10 pence

Number of Warrants

Term (from February 2014)

 

Exercise Price (pence)

5,071,429

2 yrs

10 pence

 

Note: Brad Mills' interest comprises 1,158,377 Shares that he owns directly; and a further 42,496,856 Shares that are owned by Plinian of which Brad Mills is the controlling shareholder, and includes 10,142,858 Shares that are owned by CE Mining, which is 50 per cent. owned by Plinian and warrants to subscribe for 5,071,429 Shares that are owned by Fund SPV, which is 100% owned by Fund GP of which Brad Mills is the indirect controlling shareholder.

 

For further information contact:

West African Minerals Corporation

Brad Mills

 

+44 (0) 20 7730 7486

Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish

Michael Cornish

 

+44 (0)20 7628 3396

SP Angel Corporate Finance LLP (Broker)

Ewan Leggat/Katy Birkin

 

+44 (0) 20 3470 0500

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSPGUQGMUPAGMC
Date   Source Headline
19th May 20238:00 amRNSADS Program collapse
15th May 20237:00 amRNSChange of Record Time and Last Day of Dealings
11th May 202312:00 pmRNSWebull Corporate Communications Service Platform
11th May 20237:00 amRNSChange of Delisting Date to 22 May 2023
3rd May 20231:00 pmRNSResult of Meeting
3rd May 20237:00 amRNSPresentation on OK-101 at ASCRS
2nd May 20237:00 amRNSFirst-Patient First-Visit for Phase 2 Trial
25th Apr 20237:00 amRNSActivation of First Clinical Trial Site in the U.S
5th Apr 20237:00 amRNSNOTICE OF GENERAL MEETING AND CIRCULAR PUBLICATION
4th Apr 20237:00 amRNSNotice Of Intention To Delist From The LSE
30th Mar 20237:00 amRNSDirector Acquires Shares
29th Mar 20237:00 amRNSDirector acquires shares
24th Mar 20237:00 amRNSDirector/PDMR Shareholding
16th Mar 20237:01 amRNSListing of Trial on the ClinicalTrials.gov Website
16th Mar 20237:00 amRNSClosing of Global Private Placement
15th Mar 20237:01 amRNSDirector/PDMR Dealings
14th Mar 20237:00 amRNSIssue of Equity
13th Mar 20233:16 pmRNSCEO Interview
6th Mar 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSCustom Clearance of GMP Packaged OK-101 Drug
23rd Feb 20237:00 amRNSAppointment to Scientific Advisory Board
21st Feb 20237:00 amRNSCorporate Presentation
20th Feb 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20232:05 pmRNSSecond Price Monitoring Extn
20th Feb 20232:00 pmRNSPrice Monitoring Extension
20th Feb 202311:05 amRNSSecond Price Monitoring Extn
20th Feb 202311:00 amRNSPrice Monitoring Extension
20th Feb 20239:05 amRNSSecond Price Monitoring Extn
20th Feb 20239:00 amRNSPrice Monitoring Extension
17th Feb 20234:40 pmRNSSecond Price Monitoring Extn
17th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20237:00 amRNSAllotment of Shares and Total Voting Rights
10th Jan 20234:40 pmRNSSecond Price Monitoring Extn
10th Jan 20234:35 pmRNSPrice Monitoring Extension
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
3rd Jan 20231:15 pmRNSInterim Results - availability
30th Dec 20227:00 amRNSInterim Results for the Six Months Ending 30Sept22
22nd Dec 20227:00 amRNSU.S. FDA Clearance of IND Application for OK-101
21st Dec 20227:00 amRNSOKYO to Participate at Biotech Showcase
6th Dec 20227:00 amRNSOKYO files a registration statement with the SEC
1st Dec 20227:00 amRNSChange of Auditor
24th Nov 20227:00 amRNSDirector/PDMR Shareholding
21st Nov 20227:00 amRNSU.S. IND Filing on OK-101 for the Treatment of DED
20th Oct 20227:00 amRNSOKYO to participate at 2022 ThinkEquity Conference
8th Sep 20222:30 pmRNSOKYO interview on Bloomberg: RedChip Money Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.